Citations for
1GCGR, GIPR, GLP1R
Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN, Nøhr AC, Wismann P, Iversen H, Bräuner-Osborne H, Knudsen SM, Waldhoer M.
J Biol Chem 290(2):1233-43. doi: 10.1074/jbc.M114.592436. Epub 2014 Dec 1. 2015
2ADCY5, GIPR, VPS13C
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O'Connell J, Ingelsson E, Couper DJ, Rice K, Song K, Andreasen CH, Dina C, Köttgen A, Le Bacquer O, Pattou F, Taneera J, Steinthorsdottir V, Rybin D, Ardlie K, Sampson M, Qi L, van Hoek M, Weedon MN, Aulchenko YS, Voight BF, Grallert H, Balkau B, Bergman RN, Bielinski SJ, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Böttcher Y, Brunner E, Buchanan TA, Bumpstead SJ, Cavalcanti-Proença C, Charpentier G, Chen YD, Chines PS, Collins FS, Cornelis M, J Crawford G, Delplanque J, Doney A, Egan JM, Erdos MR, Firmann M, Forouhi NG, Fox CS, Goodarzi MO, Graessler J, Hingorani A, Isomaa B, Jørgensen T, Kivimaki M, Kovacs P, Krohn K, Kumari M, Lauritzen T, Lévy-Marchal C, Mayor V, McAteer JB, Meyre D, Mitchell BD, Mohlke KL, Morken MA, Narisu N, Palmer CN, Pakyz R, Pascoe L, Payne F, Pearson D, Rathmann W, Sandbaek A, Sayer AA, Scott LJ, Sharp SJ, Sijbrands E, Singleton A, Siscovick DS, Smith NL, Sparsø T, Swift AJ, Syddall H, Thorleifsson G, Tönjes A, Tuomi T, Tuomilehto J, Valle TT, Waeber G, Walley A, Waterworth DM, Zeggini E, Zhao JH; GIANT consortium; MAGIC investigators, Illig T, Wichmann HE, Wilson JF, van Duijn C, Hu FB, Morris AD, Frayling TM, Hattersley AT, Thorsteinsdottir U, Stefansson K, Nilsson P, Syvänen AC, Shuldiner AR, Walker M, Bornstein SR, Schwarz P, Williams GH, Nathan DM, Kuusisto J, Laakso M, Cooper C, Marmot M, Ferrucci L, Mooser V, Stumvoll M, Loos RJ, Altshuler D, Psaty BM, Rotter JI, Boerwinkle E, Hansen T, Pedersen O, Florez JC, McCarthy MI, Boehnke M, Barroso I, Sladek R, Froguel P, Meigs JB, Groop L, Wareham NJ, Watanabe RM.
Nat Genet 42(2):142-8. Epub 2010 Jan 17.PMID: 20081857 2010
3GIPR
Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand.
Yaqub T, Tikhonova IG, Lättig J, Magnan R, Laval M, Escrieut C, Boulègue C, Hewage C, Fourmy D.
Mol Pharmacol 77(4):547-58. Epub 2010 Jan 8.PMID: 20061446 2010
4GIPR
Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups.
Vogel CI, Scherag A, Brönner G, Nguyen TT, Wang HJ, Grallert H, Bornhorst A, Rosskopf D, Völzke H, Reinehr T, Rief W, Illig T, Wichmann HE, Schäfer H, Hebebrand J, Hinney A.
BMC Med Genet 10:19.PMID: 19254363 2009
5GIP, GIPR
Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA, Gasis M, Thorens B, Müller HW, Bosse F.
J Neurosci Res 87(8):1858-70.PMID: 19170165 2009
6GIP, GIPR
Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
Weaver RE, Donnelly D, Wabitsch M, Grant PJ, Balmforth AJ.
Int J Obes (Lond) 32(11):1705-11. Epub 2008 Sep 9.PMID: 18779825 2008
7GIP, GIPR
Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.
Song DH, Getty-Kaushik L, Tseng E, Simon J, Corkey BE, Wolfe MM.
Gastroenterology 133(6):1796-805. Epub 2007 Sep 14.PMID: 18054552 2007
8GIP, GIPR
Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes.
Yamada C, Yamada Y, Tsukiyama K, Yamada K, Yamane S, Harada N, Miyawaki K, Seino Y, Inagaki N.
Biochem Biophys Res Commun 364(1):175-80. Epub 2007 Oct 9.PMID: 17937928 2007
9GIP, GIPR
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion.
Tsukiyama K, Yamada Y, Yamada C, Harada N, Kawasaki Y, Ogura M, Bessho K, Li M, Amizuka N, Sato M, Udagawa N, Takahashi N, Tanaka K, Oiso Y, Seino Y.
Mol Endocrinol 20(7):1644-51. Epub 2006 Feb 9.PMID: 16469773 2006
10GIPR
The Sp transcription factor family is involved in the cellular expression of the human GIP-R gene promoter.
Baldacchino V, Oble S, Hamet P, Tremblay J, Bourdeau I, Lacroix A.
Endocr Res 30(4):805-6. No abstract available. 2004
11GIPR
Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1.
Ding KH, Zhong Q, Isales CM.
Am J Physiol Endocrinol Metab 285(2):E390-6. Epub 2003 Apr 29. 2003
12GIPR
Identification of two missense mutations in the GIP receptor gene : a functional study and association analysis with NIDDM. No evidence of association with Japanese NIDDM subjects.
Kubota A, et al.
Diabetes 45 : 1701-1705. 1996
13GIPR
Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA.
Yamada Y, Hayami T, Nakamura K, Kaisaki PJ, Someya Y, Wang CZ, Seino S, Seino Y.
Genomics 29(3):773-6. 1995
14GIPR
Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor.
Gremlich S, et al.
Diabetes 44 : 1202-1208. 1995
15GIPR
Assignment of the gastric inhibitory polypeptide receptor gene (GIPR) to chromosome bands 19q13.2-q13.3 by fluorescence in situ hybridization.
Stoffel M, et al.
Genomics 28 : 607-609. 1995